1. Home
  2. Analysis
  3. Zyprexa
  4. Differential-white-blood-cell-count-abnormal

Zyprexa and Differential white blood cell count abnormal - a phase IV clinical study of FDA data

Summary:

Differential white blood cell count abnormal is reported as a side effect among people who take Zyprexa (olanzapine), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Keppra, and have Psychotic disorder.

The phase IV clinical study analyzes which people have Differential white blood cell count abnormal when taking Zyprexa. It is created by eHealthMe based on reports of 63,412 people who have side effects when taking Zyprexa from the FDA, and is updated regularly.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,724 Zyprexa users. Check the latest studies of Zyprexa.

What is Differential white blood cell count abnormal?

Differential white blood cell count abnormal is found to be associated with 89 drugs and 290 conditions by eHealthMe. Check the latest studies of Differential white blood cell count abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

63,412 people reported to have side effects when taking Zyprexa.
Among them, 13 people (0.02%) have Differential white blood cell count abnormal.

Could Zyprexa cause Differential white blood cell count abnormal?

Among these 13 people:

How long have people been on Zyprexa when they have Differential white blood cell count abnormal? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Differential white blood cell count abnormal when taking Zyprexa? *

  • female: 53.85 %
  • male: 46.15 %

What is the age of people who have Differential white blood cell count abnormal when taking Zyprexa? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 30.77 %
  • 30-39: 7.69 %
  • 40-49: 7.69 %
  • 50-59: 15.38 %
  • 60+: 38.46 %

What are other drugs people take besides Zyprexa? *

  1. Keppra: 3 people, 23.08%
  2. Lorazepam: 2 people, 15.38%
  3. Zinacef: 1 person, 7.69%
  4. Fenofibrate: 1 person, 7.69%
  5. Akineton: 1 person, 7.69%
  6. Amoxapine: 1 person, 7.69%
  7. Carbamazepine: 1 person, 7.69%
  8. Cephalexin: 1 person, 7.69%
  9. Clonazepam: 1 person, 7.69%
  10. Clozapine: 1 person, 7.69%

What are other side effects people have besides Differential white blood cell count abnormal? *

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 38.46%
  2. Thrombocytopenia (decrease of platelets in blood): 3 people, 23.08%
  3. Haematocrit Decreased: 3 people, 23.08%
  4. Overdose: 3 people, 23.08%
  5. Neutrophil Toxic Granulation Present (dark coarse granules found in granulocytes): 2 people, 15.38%
  6. Electrocardiogram T Wave Inversion: 1 person, 7.69%
  7. Hallucination, Auditory (perceiving sounds without auditory stimulus): 1 person, 7.69%
  8. Haematemesis (vomiting of blood): 1 person, 7.69%
  9. Fever: 1 person, 7.69%
  10. Fatty Liver: 1 person, 7.69%

What are the existing conditions these people have? *

  1. Psychotic Disorder: 3 people, 23.08%
  2. Psychotic Disorder Due To A General Medical Condition: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Zyprexa and have Differential white blood cell count abnormal?

- Check whether Differential white blood cell count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zyprexa:

Differential white blood cell count abnormal treatments and more:

How severe was Differential white blood cell count abnormal and when was it recovered:

Expand to all the drugs that have ingredients of olanzapine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Differential white blood cell count abnormal:

Browse all the conditions that are associated with Differential white blood cell count abnormal:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.